Department of Abdominal Imaging, Unité 965 INSERM/Paris7, Hôpital Lariboisière-AP-HP and Université Diderot-Paris 7, 2, rue Ambroise Paré, 75475 Paris Cedex 10, France.
Eur J Radiol. 2011 Nov;80(2):245-52. doi: 10.1016/j.ejrad.2010.06.027. Epub 2010 Jul 21.
The purpose of this study was to retrospectively compare the respective sensitivities of diffusion-weighted (DW), T2-weighted fast spin-echo (T2WFSE) and gadolinium chelate-enhanced MR imaging in the preoperative detection of hepatic metastases using intraoperative ultrasonographic and histopathologic findings as the standard of reference.
Twenty-seven patients with 64 surgically and histopathologically proven hepatic metastases had MR imaging of the liver, including DW, T2WFSE and dynamic gadolinium chelate-enhanced MR imaging. Images from each MR sequence were separately analyzed by two readers with disagreements resolved by consensus readings. The findings on MR images were compared with intraoperative ultrasonographic and histopathologic findings on a lesion-by-lesion basis to determine the sensitivity of each MR sequence. Statistical review of the lesion-by-lesion analysis was performed with the McNemar test.
DW, T2WFSE and gadolinium chelate-enhanced MR imaging allowed the depiction of 54/64 (84.4%; 95% CI: 73.1-92.2%), 44/64 (68.8%; 95% CI: 55.9-79.8%), and 51/64 (79.7%; 95% CI: 67.8-88.7%) hepatic metastases respectively. DW MR images allowed depiction of significantly more hepatic metastases than did T2WFSE and was equivalent to gadolinium chelate-enhanced MR imaging (P=.002 and P=.375, respectively).
DW MR imaging is superior to T2WFSE imaging and equivalent to gadolinium chelate-enhanced MR imaging for the preoperative detection of hepatic metastases. Further studies however are needed to determine at what extent DW MR imaging can be used as an alternative to gadolinium chelate-enhanced MR imaging for the preoperative depiction of hepatic metastases.
本研究旨在回顾性比较磁共振弥散加权(DW)、T2 加权快速自旋回波(T2WFSE)和钆螯合物增强 MR 成像在术前检测肝转移中的各自敏感性,以术中超声和组织病理学发现为参考标准。
27 例 64 个经手术和组织病理学证实的肝转移患者行肝脏 MR 成像,包括 DW、T2WFSE 和动态钆螯合物增强 MR 成像。两名读者分别对每个 MR 序列的图像进行分析,有分歧的地方通过共识阅读来解决。对 MR 图像上的发现与术中超声和组织病理学上的发现进行逐个病灶比较,以确定每个 MR 序列的敏感性。对病灶进行病变分析的统计回顾采用 McNemar 检验。
DW、T2WFSE 和钆螯合物增强 MR 成像分别能够显示 54/64(84.4%;95%可信区间:73.1-92.2%)、44/64(68.8%;95%可信区间:55.9-79.8%)和 51/64(79.7%;95%可信区间:67.8-88.7%)个肝转移灶。DW MR 图像能够显示的肝转移灶明显多于 T2WFSE 图像,与钆螯合物增强 MR 成像相当(P=.002 和 P=.375)。
DW MR 成像在术前检测肝转移方面优于 T2WFSE 成像,与钆螯合物增强 MR 成像相当。然而,还需要进一步的研究来确定 DW MR 成像在多大程度上可以替代钆螯合物增强 MR 成像用于术前肝转移的显示。